Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Roche at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Roche brings 1 presentation to SITC 2026 in Phoenix. Its program centres on industry strategy for cancer drug development. Roche sets out its approach to advancing oncology, drawing on a portfolio that spans bispecific antibodies and the PD-L1 drug atezolizumab.

OrganizationSITC 2026 Attendance
Roche
Basel, Switzerland
roche.com
Large pharma
Swiss pharmaceutical and diagnostics company whose oncology portfolio includes the PD-L1 antibody atezolizumab and bispecific antibodies.
Talk
Thu Nov 5
6:15pm–6:35pm
Session
Thu Nov 5
6:55pm–7:15pm
Panel

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Roche

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction